United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Energy Industry News Can mature gas fields like Balsam still surprise investors with low-risk upside? Can recompletions like Balsam-3 unlock low-risk gas upside? Dana Gas thinks so—here’s why mature fields may be MENA’s next growth lever. byPallavi MadhirajuJuly 29, 2025